An assessment of the interaction between cholecystokinin and the opiates within a drug discrimination procedure.
Recently, cholecystokinin (CCK) has been reported to antagonize a variety of opiate-induced effects, including nociception, body shaking, thermoregulation, and locomotion. Consistent with these results, a number of CCK antagonists potentiate the opiates in a range of behavioral and physiological assessments. The present study further examined the interaction between CCK and the opiates within the conditioned taste aversion baseline of drug discrimination learning, a design that utilizes the stimulus properties of the drug to control consummatory behavior. Specifically, animals injected with CCK prior to saccharin-LiCl pairings and the CCK vehicle prior to saccharin alone rapidly acquired the CCK-vehicle discrimination, avoiding saccharin consumption following the administration of CCK and consuming the same saccharin solution following the vehicle. Although the stimulus properties of CCK did not generalize to either naloxone or diprenorphine, morphine blocked and naloxone potentiated CCK's stimulus effects. These data are thus consistent with a physiological (rather than a pharmacological) interaction between CCK and the opiates.
Melton
P M
PM
Department of Psychology, American University, Washington, DC 20016-8062.
Riley
A L
AL
D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects; D002766:Cholecystokinin / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004174:Diprenorphine / Q000494:pharmacology; D004192:Discrimination, Psychological / Q000187:drug effects*; D004347:Drug Interactions; D005260:Female; D005793:Generalization, Psychological / Q000187:drug effects; D018021:Lithium Chloride / Q000494:pharmacology; D009020:Morphine / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D009294:Narcotics / Q000494:pharmacology*; D051381:Rats
D009292:Narcotic Antagonists; D009294:Narcotics; D004174:Diprenorphine; D009270:Naloxone; D009020:Morphine; D002766:Cholecystokinin; D018021:Lithium Chloride